Twilio withdrew its previous target of 30% annual revenue growth and said it was now targeting a range of15%-25%. Read More...
Motley Fool
Why Teva Stock Sank On Thursday
Thursday was an eventful day for drug maker Teva Pharmaceutical Industries (NYSE: TEVA). Not only did the company release its latest set of quarterly earnings, it also reached a settlement in a major lawsuit. Arguably, the more important development is the legal settlement, in which Teva has agreed to pay a total of $523 million to the state of New York.
